Found: 30
Select item for more details and to access through your institution.
Mediation analysis of racial disparities in triple-negative breast cancer incidence among postmenopausal women.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 283, doi. 10.1007/s10549-021-06158-y
- By:
- Publication type:
- Article
Breast cancer survivors: physical and mental quality of life 10 years following diagnosis, a case-control study.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 273, doi. 10.1007/s10549-021-06156-0
- By:
- Publication type:
- Article
Mammography use and breast cancer incidence among older U.S. women.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 307, doi. 10.1007/s10549-021-06160-4
- By:
- Publication type:
- Article
Male and female breast cancer: the two faces of the same genetic susceptibility coin.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 295, doi. 10.1007/s10549-021-06159-x
- By:
- Publication type:
- Article
Association between physical activity and subsequent cardiovascular disease among 5-year breast cancer survivors.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 203, doi. 10.1007/s10549-021-06140-8
- By:
- Publication type:
- Article
Reply to the letter on sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Trastuzumab-induced cardiotoxicity: a review of clinical risk factors, pharmacologic prevention, and cardiotoxicity of other HER2-directed therapies.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 21, doi. 10.1007/s10549-021-06280-x
- By:
- Publication type:
- Article
Barriers and engagement in breast cancer survivorship wellness activities.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 317, doi. 10.1007/s10549-021-06279-4
- By:
- Publication type:
- Article
Observations with alpelisib in older patients (≥ 65 year of age) with breast cancer in a non-clinical trial setting.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 15, doi. 10.1007/s10549-021-06277-6
- By:
- Publication type:
- Article
Activity of trastuzumab emtansine (T-DM1) in 3D cell culture.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 65, doi. 10.1007/s10549-021-06272-x
- By:
- Publication type:
- Article
The prognostic significance of Flap Endonuclease 1 (FEN1) in breast ductal carcinoma in situ.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 53, doi. 10.1007/s10549-021-06271-y
- By:
- Publication type:
- Article
Evaluation of endocrine resistance using ESR1 genotyping of circulating tumor cells and plasma DNA.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 43, doi. 10.1007/s10549-021-06270-z
- By:
- Publication type:
- Article
M2 tumor-associated macrophages play important role in predicting response to neoadjuvant chemotherapy in triple-negative breast carcinoma.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 37, doi. 10.1007/s10549-021-06260-1
- By:
- Publication type:
- Article
Clinical and genomic assessment of PD-L1 SP142 expression in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 165, doi. 10.1007/s10549-021-06193-9
- By:
- Publication type:
- Article
Incidence of cardiotoxicity and validation of the Heart Failure Association-International Cardio-Oncology Society risk stratification tool in patients treated with trastuzumab for HER2-positive early breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 149, doi. 10.1007/s10549-021-06192-w
- By:
- Publication type:
- Article
Prosigna test in breast cancer: real-life experience.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 141, doi. 10.1007/s10549-021-06191-x
- By:
- Publication type:
- Article
LncRNA SNHG6 promotes breast cancer progression and epithelial-mesenchymal transition via miR-543/LAMC1 axis.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
DUCHESS: an evaluation of the ductal carcinoma in situ score for decisions on radiotherapy in patients with low/intermediate-risk DCIS.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 133, doi. 10.1007/s10549-021-06187-7
- By:
- Publication type:
- Article
Eribulin-based neoadjuvant chemotherapy for triple-negative breast cancer patients stratified by homologous recombination deficiency status: a multicenter randomized phase II clinical trial.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 117, doi. 10.1007/s10549-021-06184-w
- By:
- Publication type:
- Article
Prediction of pathological complete response after neoadjuvant chemotherapy in breast cancer: comparison of diagnostic performances of dedicated breast PET, whole-body PET, and dynamic contrast-enhanced MRI.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 107, doi. 10.1007/s10549-021-06179-7
- By:
- Publication type:
- Article
Comparison of mastectomy and breast reconstruction outcomes using low thermal dissection versus traditional electrocautery: a blinded randomized trial.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 101, doi. 10.1007/s10549-021-06177-9
- By:
- Publication type:
- Article
Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 91, doi. 10.1007/s10549-021-06175-x
- By:
- Publication type:
- Article
Safety and efficacy of everolimus (EVE) plus exemestane (EXE) in postmenopausal women with locally advanced or metastatic breast cancer: final results from EVEREXES.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 77, doi. 10.1007/s10549-021-06173-z
- By:
- Publication type:
- Article
Impact of age, rurality and distance in predicting contralateral prophylactic mastectomy for breast cancer in a Midwestern state: a population-based study.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 191, doi. 10.1007/s10549-021-06105-x
- By:
- Publication type:
- Article
Variations in breast cancer surgical treatment and timing: determinants and disparities.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 259, doi. 10.1007/s10549-021-06155-1
- By:
- Publication type:
- Article
The impact of body mass index on breast cancer incidence among women at increased risk: an observational study from the International Breast Intervention Studies.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 215, doi. 10.1007/s10549-021-06141-7
- By:
- Publication type:
- Article
Characterization of estrogen receptor-low-positive breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 225, doi. 10.1007/s10549-021-06148-0
- By:
- Publication type:
- Article
Neoadjuvant endocrine therapy use in early stage breast cancer during the covid-19 pandemic.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 249, doi. 10.1007/s10549-021-06153-3
- By:
- Publication type:
- Article
Thai patients who fulfilled NCCN criteria for breast/ovarian cancer genetic assessment demonstrated high prevalence of germline mutations in cancer susceptibility genes: implication to Asian population testing.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 237, doi. 10.1007/s10549-021-06152-4
- By:
- Publication type:
- Article
Baseline characteristics and first-line treatment patterns in patients with HER2-positive metastatic breast cancer in the SystHERs registry.
- Published in:
- Breast Cancer Research & Treatment, 2021, v. 188, n. 1, p. 179, doi. 10.1007/s10549-021-06103-z
- By:
- Publication type:
- Article